Hologic, Inc. to Release First Quarter Fiscal 2013 Operating Results on Monday, February 4, 2013

BEDFORD, Mass., Jan. 4, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced plans to release its first quarter fiscal 2013 operating results on Monday, February 4, 2013 after market close. In conjunction with the release, management will host a conference call on Monday, February 4, 2013, at 5:00 p.m. (Eastern).

Interested participants may listen to the call by dialing 888-523-1227 or 719-457-2632 for international callers and referencing participant code 5124529 approximately 15 minutes prior to the call on February 4th. For those unable to participate in the live broadcast, a replay will be available one hour after the call ends through Friday, February 22, 2013, at 888-203-1112 or 719-457-0820 for international callers, access code 5124529.

The Company will also provide a live webcast of the call. Interested participants may access the webcast on the Company's website at http://www.hologic.com/investors-overview. A replay of the call will be archived on the Company's website and a PowerPoint presentation related to the conference call will be posted to the site after market close on Monday, February 4, 2013.

About Hologic, Inc.

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products. The Company operates four core business units focused on diagnostics, breast health, GYN surgical and skeletal health. With a comprehensive suite of technologies and a robust research and development program, Hologic is committed to improving lives. The Company is headquartered in Massachusetts. For more information, visit www.hologic.com.

Contacts:

Deborah R. Gordon

Al Kildani

Vice President, Investor Relations

Senior Director, Investor Relations

(781) 9997716

(858) 4108653

deborah.gordon@hologic.com

al.kildani@hologic.com

SOURCE Hologic, Inc.

Back to news